UNICREDIT BANK/CALL/ABBVIE/190/0.1/15.01.25 Share Price

Warrant

DE000HC6UWJ8

Market Closed - BOERSE MUENCHEN 20:40:23 25/06/2024 BST
0.46 EUR -9.80% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/190/0.1/15.01.25
Current month+84.00%
1 month+100.00%
Date Price Change
25/06/24 0.46 -9.80%
24/06/24 0.51 +8.51%
21/06/24 0.47 -9.62%
20/06/24 0.52 +6.12%
19/06/24 0.49 0.00%

Real-time BOERSE MUENCHEN

Last update June 25, 2024 at 08:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC6UWJ
ISINDE000HC6UWJ8
Date issued 19/05/2023
Strike 190 $
Maturity 15/01/2025 (204 Days)
Parity 10 : 1
Emission price 0.51
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.16
Lowest since issue 0.16
Delta0.29x
Omega 10.42
Premium14.03x
Gearing36.22x
Moneyness 0.8987
Difference Strike 19.25 $
Difference Strike %+10.13%
Spread 0.04
Spread %8.70%
Theoretical value 0.4500
Implied Volatility 22.37 %
Total Loss Probability 75.79 %
Intrinsic value 0.000000
Present value 0.4500
Break even 194.82 €
Theta-0.02x
Vega0.04x
Rho0.02x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
170.8 USD
Average target price
183.2 USD
Spread / Average Target
+7.31%
Consensus